Global Health has announced the approval of its unaudited standalone and consolidated financial results for Q3, ending December 31, 2025. The board approved the reappointment of Dr. Ravi Gupta and Mr. Rajan Bharti Mittal as Independent Directors and appointed Ms. Shonan Purie Trehan as a Non-Executive Non-Independent Director. Mr. Malik Mohd. Ashhab was appointed as Head-Diagnostic Services.
Financial Results for Q3 2025
The Board of Directors of Global Health approved the unaudited standalone and consolidated financial results for the third quarter and nine-month period ending December 31, 2025. Walker Chandiok & Co LLP provided a limited review report on these results.
Key Personnel Appointments and Reappointments
Several key decisions regarding the company’s leadership were made:
- Mr. Malik Mohd. Ashhab has been appointed as the ‘Head-Diagnostic Services’ and will be part of the Senior Management Personnel.
- Dr. Ravi Gupta (DIN:00023487) is re-appointed as an Independent Director for a second term of 5 years, effective July 08, 2026, subject to shareholder approval.
- Mr. Rajan Bharti Mittal (DIN:00028016) is re-appointed as an Independent Director for a second term of 5 years, effective July 08, 2026, subject to shareholder approval.
- Ms. Shonan Purie Trehan (DIN:07078955) has been appointed as a Non-Executive Non-Independent Director, liable to retire by rotation, effective March 13, 2026, subject to shareholder approval.
Standalone Financial Highlights
The standalone financial results show:
- Total Income: ₹9,648.29 million for Q3 2025.
- Profit Before Tax: ₹1,028.86 million for Q3 2025.
- Profit After Tax: ₹799.07 million for Q3 2025.
Consolidated Financial Highlights
The consolidated financial results reveal:
- Total Income: ₹11,428.29 million for Q3 2025.
- Profit Before Tax: ₹1,197.83 million for Q3 2025.
- Profit After Tax: ₹950.33 million for Q3 2025.
Source: BSE
